View ValuationSobute New Materials 향후 성장Future 기준 점검 4/6Sobute New Materials (는) 각각 연간 28.3% 및 16.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 27.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 5.8% 로 예상됩니다.핵심 정보28.3%이익 성장률27.84%EPS 성장률Chemicals 이익 성장30.0%매출 성장률16.3%향후 자기자본이익률5.79%애널리스트 커버리지Low마지막 업데이트23 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesDeclared Dividend • May 30Dividend increased to CN¥0.12Dividend of CN¥0.12 is 20% higher than last year. Ex-date: 3rd June 2026 Payment date: 3rd June 2026 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has decreased over the past 86 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 109% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Qijun Yu was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.공시 • Apr 16Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China공시 • Mar 30Sobute New Materials Co., Ltd to Report Q1, 2026 Results on Apr 28, 2026Sobute New Materials Co., Ltd announced that they will report Q1, 2026 results on Apr 28, 2026공시 • Dec 26Sobute New Materials Co., Ltd to Report Fiscal Year 2025 Results on Apr 16, 2026Sobute New Materials Co., Ltd announced that they will report fiscal year 2025 results on Apr 16, 2026공시 • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2025 Results on Oct 29, 2025Sobute New Materials Co., Ltd announced that they will report Q3, 2025 results on Oct 29, 2025공시 • Jun 30Sobute New Materials Co., Ltd to Report First Half, 2025 Results on Aug 29, 2025Sobute New Materials Co., Ltd announced that they will report first half, 2025 results on Aug 29, 2025공시 • Apr 29Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025, at 09:30 China Standard Time.공시 • Mar 28Sobute New Materials Co., Ltd to Report Q1, 2025 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report Q1, 2025 results on Apr 29, 2025공시 • Dec 27Sobute New Materials Co., Ltd to Report Fiscal Year 2024 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report fiscal year 2024 results on Apr 29, 2025Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥912.4m (flat on 3Q 2023). Net income: CN¥25.3m (down 43% from 3Q 2023). Profit margin: 2.8% (down from 4.9% in 3Q 2023). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings.공시 • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024Sobute New Materials Co., Ltd announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥7.57, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.Reported Earnings • Aug 27Second quarter 2024 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.069 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥984.5m (down 1.0% from 2Q 2023). Net income: CN¥32.2m (down 43% from 2Q 2023). Profit margin: 3.3% (down from 5.7% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.공시 • Jun 28Sobute New Materials Co., Ltd to Report First Half, 2024 Results on Aug 27, 2024Sobute New Materials Co., Ltd announced that they will report first half, 2024 results on Aug 27, 2024Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥9.48, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.공시 • Apr 28Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu ChinaReported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.10 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.05 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥578.6m (down 13% from 1Q 2023). Net income: CN¥21.1m (down 48% from 1Q 2023). Profit margin: 3.6% (down from 6.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.공시 • Mar 29Sobute New Materials Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report Q1, 2024 results on Apr 26, 2024Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥7.94, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years.New Risk • Jan 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (109% cash payout ratio). Profit margins are more than 30% lower than last year (5.4% net profit margin). Shareholders have been diluted in the past year (3.0% increase in shares outstanding).공시 • Dec 30Sobute New Materials Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report fiscal year 2023 results on Apr 26, 2024Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.11 (down from CN¥0.17 in 3Q 2022). Revenue: CN¥915.6m (down 5.1% from 3Q 2022). Net income: CN¥44.5m (down 38% from 3Q 2022). Profit margin: 4.9% (down from 7.4% in 3Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥994.9m (down 3.7% from 2Q 2022). Net income: CN¥56.6m (down 33% from 2Q 2022). Profit margin: 5.7% (down from 8.1% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 23Full year 2022 earnings released: EPS: CN¥0.69 (vs CN¥1.27 in FY 2021)Full year 2022 results: EPS: CN¥0.69 (down from CN¥1.27 in FY 2021). Revenue: CN¥3.71b (down 18% from FY 2021). Net income: CN¥287.9m (down 46% from FY 2021). Profit margin: 7.8% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥18.41, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 8.9% over the past year.Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Employees Representative Member of the Supervisory Board Hua Li is the most experienced director on the board, commencing their role in 2021. Independent Director Lily Li was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.36 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.36 in 3Q 2021). Revenue: CN¥965.3m (down 19% from 3Q 2021). Net income: CN¥71.4m (down 53% from 3Q 2021). Profit margin: 7.4% (down from 13% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.33 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.20 (down from CN¥0.33 in 2Q 2021). Revenue: CN¥1.03b (down 19% from 2Q 2021). Net income: CN¥83.9m (down 39% from 2Q 2021). Profit margin: 8.1% (down from 11% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 38%, compared to a 40% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 30First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2021). Revenue: CN¥716.2m (down 7.3% from 1Q 2021). Net income: CN¥80.2m (up 2.8% from 1Q 2021). Profit margin: 11% (up from 10% in 1Q 2021). The increase in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.Reported Earnings • Apr 17Full year 2021 earnings released: EPS: CN¥1.27 (vs CN¥1.16 in FY 2020)Full year 2021 results: EPS: CN¥1.27 (up from CN¥1.16 in FY 2020). Revenue: CN¥4.52b (up 24% from FY 2020). Net income: CN¥532.8m (up 21% from FY 2020). Profit margin: 12% (in line with FY 2020). Over the next year, revenue is forecast to grow 25%, compared to a 50% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥25.19, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past year.Valuation Update With 7 Day Price Move • Nov 20Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥21.95, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China.Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.36 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.19b (up 16% from 3Q 2020). Net income: CN¥151.0m (up 11% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020).Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.32 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.27b (up 27% from 2Q 2020). Net income: CN¥137.8m (up 17% from 2Q 2020). Profit margin: 11% (in line with 2Q 2020).Reported Earnings • Apr 26First quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.16 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥772.4m (up 82% from 1Q 2020). Net income: CN¥78.1m (up 58% from 1Q 2020). Profit margin: 10% (down from 12% in 1Q 2020). The decrease in margin was driven by higher expenses.Reported Earnings • Mar 27Full year 2020 earnings released: EPS CN¥1.39 (vs CN¥1.14 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.65b (up 11% from FY 2019). Net income: CN¥440.8m (up 24% from FY 2019). Profit margin: 12% (up from 11% in FY 2019). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥27.30, the stock is trading at a trailing P/E ratio of 21x, up from the previous P/E ratio of 17.9x. This compares to an average P/E of 35x in the Chemicals industry in China.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥26.62, the stock is trading at a trailing P/E ratio of 20.5x, up from the previous P/E ratio of 17.7x. This compares to an average P/E of 36x in the Chemicals industry in China.이익 및 매출 성장 예측XSSC:603916 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20285,617279N/A493112/31/20274,849219N/A359112/31/20264,140162N/A30613/31/20263,570127273432N/A12/31/20253,556121164371N/A9/30/20253,657111342545N/A6/30/20253,665106214474N/A3/31/20253,65899349632N/A12/31/20243,55596334581N/A9/30/20243,48298125423N/A6/30/20243,485117338606N/A3/31/20243,495141-6294N/A12/31/20233,58216032370N/A9/30/20233,576194119437N/A6/30/20233,626221-126212N/A3/31/20233,66424837381N/A12/31/20223,715288-78219N/A9/30/20224,004401-136169N/A6/30/20224,224481-3311N/A3/31/20224,466535-43242N/A12/31/20214,52253339336N/A9/30/20214,434505-279168N/A6/30/20214,268490-260130N/A3/31/20213,999470-41336N/A12/31/20203,652441-14333N/A9/30/20203,456406273482N/A6/30/20203,348387215396N/A3/31/20203,264355260432N/A12/31/20193,307354N/A419N/A9/30/20193,017297N/A144N/A6/30/20192,750228N/A3N/A3/31/20192,427287N/A-13N/A12/31/20182,316268N/A-98N/A9/30/20182,100241N/A-255N/A6/30/20181,912239N/A-157N/A3/31/20181,773129N/A-185N/A12/31/20171,680134N/A-121N/A9/30/20171,553154N/A161N/A6/30/20171,450147N/A179N/A3/31/20171,284140N/A169N/A12/31/20161,314133N/A155N/A6/30/20161,259145N/A50N/A3/31/20161,287158N/A63N/A12/31/20151,314171N/A75N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 603916 의 연간 예상 수익 증가율(28.3%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 603916 의 연간 수익(28.3%)이 CN 시장(27.1%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 603916 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 603916 의 수익(연간 16.3%)이 CN 시장(연간 16.4%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 603916 의 수익(연간 16.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 603916의 자본 수익률은 3년 후 5.8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/03 19:12종가2026/06/03 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Sobute New Materials Co., Ltd는 5명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Maoda YangChina International Capital Corporation LimitedWei LiuHaitong International Research LimitedYanhe FangHuatai Research2명의 분석가 더 보기
Declared Dividend • May 30Dividend increased to CN¥0.12Dividend of CN¥0.12 is 20% higher than last year. Ex-date: 3rd June 2026 Payment date: 3rd June 2026 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has decreased over the past 86 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 109% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Qijun Yu was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
공시 • Apr 16Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
공시 • Mar 30Sobute New Materials Co., Ltd to Report Q1, 2026 Results on Apr 28, 2026Sobute New Materials Co., Ltd announced that they will report Q1, 2026 results on Apr 28, 2026
공시 • Dec 26Sobute New Materials Co., Ltd to Report Fiscal Year 2025 Results on Apr 16, 2026Sobute New Materials Co., Ltd announced that they will report fiscal year 2025 results on Apr 16, 2026
공시 • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2025 Results on Oct 29, 2025Sobute New Materials Co., Ltd announced that they will report Q3, 2025 results on Oct 29, 2025
공시 • Jun 30Sobute New Materials Co., Ltd to Report First Half, 2025 Results on Aug 29, 2025Sobute New Materials Co., Ltd announced that they will report first half, 2025 results on Aug 29, 2025
공시 • Apr 29Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025, at 09:30 China Standard Time.
공시 • Mar 28Sobute New Materials Co., Ltd to Report Q1, 2025 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report Q1, 2025 results on Apr 29, 2025
공시 • Dec 27Sobute New Materials Co., Ltd to Report Fiscal Year 2024 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report fiscal year 2024 results on Apr 29, 2025
Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥912.4m (flat on 3Q 2023). Net income: CN¥25.3m (down 43% from 3Q 2023). Profit margin: 2.8% (down from 4.9% in 3Q 2023). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings.
공시 • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024Sobute New Materials Co., Ltd announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥7.57, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.
Reported Earnings • Aug 27Second quarter 2024 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.069 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥984.5m (down 1.0% from 2Q 2023). Net income: CN¥32.2m (down 43% from 2Q 2023). Profit margin: 3.3% (down from 5.7% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.
공시 • Jun 28Sobute New Materials Co., Ltd to Report First Half, 2024 Results on Aug 27, 2024Sobute New Materials Co., Ltd announced that they will report first half, 2024 results on Aug 27, 2024
Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥9.48, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.
공시 • Apr 28Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
Reported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.10 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.05 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥578.6m (down 13% from 1Q 2023). Net income: CN¥21.1m (down 48% from 1Q 2023). Profit margin: 3.6% (down from 6.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
공시 • Mar 29Sobute New Materials Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report Q1, 2024 results on Apr 26, 2024
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥7.94, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years.
New Risk • Jan 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (109% cash payout ratio). Profit margins are more than 30% lower than last year (5.4% net profit margin). Shareholders have been diluted in the past year (3.0% increase in shares outstanding).
공시 • Dec 30Sobute New Materials Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report fiscal year 2023 results on Apr 26, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.11 (down from CN¥0.17 in 3Q 2022). Revenue: CN¥915.6m (down 5.1% from 3Q 2022). Net income: CN¥44.5m (down 38% from 3Q 2022). Profit margin: 4.9% (down from 7.4% in 3Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥994.9m (down 3.7% from 2Q 2022). Net income: CN¥56.6m (down 33% from 2Q 2022). Profit margin: 5.7% (down from 8.1% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 23Full year 2022 earnings released: EPS: CN¥0.69 (vs CN¥1.27 in FY 2021)Full year 2022 results: EPS: CN¥0.69 (down from CN¥1.27 in FY 2021). Revenue: CN¥3.71b (down 18% from FY 2021). Net income: CN¥287.9m (down 46% from FY 2021). Profit margin: 7.8% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥18.41, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 8.9% over the past year.
Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Employees Representative Member of the Supervisory Board Hua Li is the most experienced director on the board, commencing their role in 2021. Independent Director Lily Li was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.36 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.36 in 3Q 2021). Revenue: CN¥965.3m (down 19% from 3Q 2021). Net income: CN¥71.4m (down 53% from 3Q 2021). Profit margin: 7.4% (down from 13% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.33 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.20 (down from CN¥0.33 in 2Q 2021). Revenue: CN¥1.03b (down 19% from 2Q 2021). Net income: CN¥83.9m (down 39% from 2Q 2021). Profit margin: 8.1% (down from 11% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 38%, compared to a 40% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 30First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2021). Revenue: CN¥716.2m (down 7.3% from 1Q 2021). Net income: CN¥80.2m (up 2.8% from 1Q 2021). Profit margin: 11% (up from 10% in 1Q 2021). The increase in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.
Reported Earnings • Apr 17Full year 2021 earnings released: EPS: CN¥1.27 (vs CN¥1.16 in FY 2020)Full year 2021 results: EPS: CN¥1.27 (up from CN¥1.16 in FY 2020). Revenue: CN¥4.52b (up 24% from FY 2020). Net income: CN¥532.8m (up 21% from FY 2020). Profit margin: 12% (in line with FY 2020). Over the next year, revenue is forecast to grow 25%, compared to a 50% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥25.19, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past year.
Valuation Update With 7 Day Price Move • Nov 20Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥21.95, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China.
Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.36 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.19b (up 16% from 3Q 2020). Net income: CN¥151.0m (up 11% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020).
Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.32 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.27b (up 27% from 2Q 2020). Net income: CN¥137.8m (up 17% from 2Q 2020). Profit margin: 11% (in line with 2Q 2020).
Reported Earnings • Apr 26First quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.16 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥772.4m (up 82% from 1Q 2020). Net income: CN¥78.1m (up 58% from 1Q 2020). Profit margin: 10% (down from 12% in 1Q 2020). The decrease in margin was driven by higher expenses.
Reported Earnings • Mar 27Full year 2020 earnings released: EPS CN¥1.39 (vs CN¥1.14 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.65b (up 11% from FY 2019). Net income: CN¥440.8m (up 24% from FY 2019). Profit margin: 12% (up from 11% in FY 2019). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥27.30, the stock is trading at a trailing P/E ratio of 21x, up from the previous P/E ratio of 17.9x. This compares to an average P/E of 35x in the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥26.62, the stock is trading at a trailing P/E ratio of 20.5x, up from the previous P/E ratio of 17.7x. This compares to an average P/E of 36x in the Chemicals industry in China.